These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. What's next after fistula first: is an arteriovenous graft or central venous catheter preferable when an arteriovenous fistula is not possible? James MT, Manns BJ, Hemmelgarn BR, Ravani P, Alberta Kidney Disease Network. Semin Dial; 2009 Jan; 22(5):539-44. PubMed ID: 19744149 [Abstract] [Full Text] [Related]
32. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3. Stefanovic V, Mitić-Zlatkovic M, Radivojevic J, Vlahovic P. Ren Fail; 2005 Jan; 27(3):283-8. PubMed ID: 15957544 [Abstract] [Full Text] [Related]
33. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis]. Fernández-Gallego J, Gutiérrez C. Nefrologia; 2003 Jan; 23(2):177-8. PubMed ID: 12778885 [No Abstract] [Full Text] [Related]
35. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients. Liu H, Peng Y, Liu F, Xiao H, Chen X, Huang A, Liu Y. Ren Fail; 2008 Jan; 30(7):685-90. PubMed ID: 18704816 [Abstract] [Full Text] [Related]
36. Impact of switch of vascular access type on key clinical and laboratory parameters in chronic haemodialysis patients. Wystrychowski G, Kitzler TM, Thijssen S, Usvyat L, Kotanko P, Levin NW. Nephrol Dial Transplant; 2009 Jul; 24(7):2194-200. PubMed ID: 19228757 [Abstract] [Full Text] [Related]
37. Vascular accesses in haemodialysis: a challenge to be met. Antón-Pérez G, Pérez-Borges P, Alonso-Almán F, Vega-Díaz N. Nefrologia; 2012 Jul; 32(1):103-7. PubMed ID: 22294008 [Abstract] [Full Text] [Related]